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license (http://creativeand prognostic purposes. Therefore, the Amsterdam IADL Questionnaire (A-IADL-Q) was devel-
oped: a 70-item proxy-based tool with good psychometric properties. We aimed to design a short
version while preserving its psychometric quality.
Methods: Study partners of subjects (n 5 1355), ranging from cognitively normal to dementia
subjects, completed the original A-IADL-Q. We selected the short version items using a stepwise
procedure combining missing data, Item Response Theory, and input from respondents and experts.
We investigated internal consistency of the short version and concordance with the original version.
To assess its construct validity, we additionally investigated concordance between the short version
and the Mini–Mental State Examination (MMSE) and Disability Assessment for Dementia (DAD).
Finally, we investigated differences in instrumental activities of daily living (IADL) scores between
diagnostic groups across the dementia spectrum.
Results: We selected 30 items covering the entire spectrum of IADL functioning. Internal consis-
tency (0.98) and concordance with the original version (0.97) were very high. Concordance with
the MMSE (0.72) and DAD (0.87) scores was high. IADL impairment scores increased across the
spectrum from normal cognition to dementia.
Discussion: The A-IADL-Q short version (A-IADL-Q-SV) consists of 30 items and has maintained
the psychometric quality of the original A-IADL-Q. As such, the A-IADL-Q-SV is a concise measure
of functional decline.
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Dementia is a syndrome characterized by progressive
cognitive decline and significant interference in daily func-
tion [1]. The first observable problems in daily life often
concern the instrumental activities of daily living (IADL).imer’s Association. This is an open access article under the CC BY-NC-ND
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tiple cognitive processes are necessary,” such as cooking,
managing finances, and driving [2]. Detecting functional
decline along the continuum from normal aging to dementia
is highly relevant for a number of reasons. First of all, subtle
IADL problems may already be present in subjects with mild
cognitive impairment (MCI) and predict progression to de-
mentia [3–5]. This suggests that assessment of IADL can
be used to select MCI subjects at an increased risk for
dementia [6]. Once a diagnosis has been established,
measuring IADL performance remains essential for the
monitoring of clinical progression [7]. Finally, IADL assess-
ment plays a pivotal role in clinical trials, particularly in the
evaluation of symptomatic treatment in dementia caused by
Alzheimer’s disease (AD) [8–10].
IADL performance is often measured using proxy-based
questionnaires [11]. Unfortunately, most of these question-
naires suffer from serious limitations. They focus on everyday
activities that are outdated and less relevant for patients in the
early stages of dementia [12]. Furthermore, psychometric
properties such as reliability, validity, and responsiveness
are often questionable or overlooked [13]. Recent studies
have pointed out that improvements in IADL instruments
are necessary, especially for detecting IADL problems in
MCI and the early stages of dementia [14–17].
To overcome the aforementioned drawbacks of existing
IADL scales, Sikkes et al. developed the Amsterdam IADL
Questionnaire (A-IADL-Q). The A-IADL-Q is a 70-item
proxy-based tool and was developed with input from clinicians,
patients, and caregivers [18]. Previous studies have reported
goodpsychometric propertieswith respect to reliability, validity,
responsiveness, and diagnostic accuracy in dementia [19–21].
One disadvantage of the A-IADL-Q is its length, resulting in
an administration time of 20 to 25 minutes. In addition,
respondents often report that some items are redundant or
unclear. To facilitate its administration and implementation on
a wider scale, we aimed to design a short and more concise
version of the A-IADL-Q.
The present article describes the development and valida-
tion of a short version of the A-IADL-Q (A-IADL-Q-SV).
We aimed to select the most informative items, using a com-
bined approach of quantitative and qualitative methods. We
expected that the short version would maintain the good psy-
chometric quality of the original A-IADL-Q. In addition, we
expected that IADL scores based on the short version would
differ between diagnostic groups across the spectrum from
normal cognition (NC) to dementia.2. Methods
2.1. Subjects
We selected 1355 subjects with different levels of cognitive
functioning, ranging fromNC to dementia. Their study partner,
mainly a spouse, relative, or friend, completed the A-IADL-Q.
We included subjects from neurologic memory clinics of theVU University Medical Center (VUmc) Alzheimer Center,
Amsterdam, The Netherlands (n 5 1117), and the Alzheimer
Center Rotterdam, The Netherlands (n 5 32), and from the
geriatric memory clinic of the VUmc, Amsterdam, The
Netherlands (n5 102).All these subjects underwent adementia
assessment, including clinical history, medical and neurologic
examination, screening laboratory tests, a neuropsychological
test battery, andbrain imaging [22].During this visit, studypart-
ners completed the A-IADL-Q on an iPad. Subjects’ diagnoses
were made in a multidisciplinary diagnostic meeting, contain-
ing at least a neurologist or geriatrician [3,22,23].
We includedcognitively normal subjects (n5 104) fromthe
Amsterdam site of the preclinAD cohort of the EuropeanMed-
ical Information Framework for AD project. Inclusion criteria
for this cohort were age60,modified telephone interview for
cognitive screening .22; Geriatric Depression Scale ,11;
Consortium to Establish a Registry for AD 10-word list de-
layed recall.21.5 standard deviation of age adjusted norma-
tive data; and Clinical Dementia Rating score of 0 with a score
on the memory subdomain of 0 [24–27]. During the baseline
visit, study partners completed the A-IADL-Q on an iPad.
Data were collected between October 2012 and August
2016. All subjects gave written informed consent and all
study partners gave oral informed consent. The Medical
Ethical Committee of the VUmc approved the study.2.2. The Amsterdam IADL Questionnaire
The original A-IADL-Q is a proxy-based scale with 70
items covering a broad range of cognitive IADL [18]. The
items can be divided into eight subcategories: household,
administration, work, computer use, leisure time, appliances,
transport, and other activities. The A-IADL-Q is computer-
ized and has an adaptive approach as the items are tailored
to individual responses (see Fig. 1). This results in aminimum
of 47 and amaximumof 70 items for each respondent. Before
the start, it is emphasized that the questionnaire addresses
day-to-day problems caused by cognitive problems, such as
memory, attention, or planning problems.Difficulty in perfor-
mance is rated on a five-point Likert scale, ranging from “no
difficulty in performing this task” to “no longer able to
perform this task.” Scoring is based on ItemResponse Theory
(IRT): a paradigm linking responses to a test battery to an un-
derlying construct (or latent trait) [28]. For theA-IADL-Q, the
construct underlying the items can be termed “IADL perfor-
mance,” that is, the latent trait reflects IADL impairment
with higher estimated trait levels indicatingmore impairment.
Linking the probabilities of category-specific item re-
sponses to latent trait levels is based on an IRT model [28].
For the A-IADL-Q, the graded response model (GRM) is
used: a polytomous IRT model appropriate for items with
ordinal response categories [29]. In the GRM, each item is
characterized by a discrimination parameter (a) and four ex-
tremity parameters (bs; the number of response categories
minus 1). The discrimination (or slope) parameter indicates
how well an item discriminates between individuals with
o Yes Did he/she find it more difficult to perform household duties than he/she had in the 
past?
o No (0)
o Yes, slightly more difficult (1)
o Yes, more difficult (2)
o Yes, much more difficult (3)
o Yes, he/she is no longer able to perform this task (4)
o No He/she did not carry out any household duties for the following reason: 
o He/she was unable to do so due to his/her cognitive problems (4)
o He/she was unable to do so due to his/her physical problems (-)
o He/she has never done that before (-)
o Other, please state ……………… (-)
Did he/she carry out household duties in the past 4 weeks?
o Don’t know Item scored as missing (-). Questionnaire skips to next item. 
Fig. 1. Example item of the A-IADL-Q, including response options and scoring. Abbreviation: A-IADL-Q, Amsterdam IADL Questionnaire.
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gest higher ability to differentiate. The extremity (or category
threshold) parameters represent the trait levels that mark the
transition between response categories (in terms of cumula-
tive probabilities for endorsement) [29]. An important advan-
tage of IRT is that one’s level of the latent trait can be
estimated from any set of items for which the parameters
are known. Therefore, IRT is able to handle missing data
that may result from an adaptive approach. IRT is often
preferred over classical scoring methods for scale develop-
ment and refinement: it advances the development of more
efficient scales by supporting item-reduction while preser-
ving measurement precision [30,31].
The following basic assumptions underlie the IRT frame-
work: (1) unidimensionality, implying that a single latent trait
underlies the items; (2) local independence, which implies in-
dependence of item responses conditional on the latent trait;
and (3) monotonicity, implying that the probability of
endorsing (a category-specific response to) an item should in-
crease as the trait level increases [32]. Previous work showed
that the A-IADL-Q could be adequately described by a single
latent factor and that the assumptions of local independence
and monotonicity were met as well [19]. Because the present
study contains a larger andmore heterogenic sample, we have
assessed these basic assumptions again.
2.3. Procedures
We divided the total sample into a training (n5 677) and
validation set (n5 678), to use independent samples for the
development and validation of the short version. Werandomly split the Alzheimer Center Rotterdam, the VUmc
geriatric, and the cognitively healthy cohorts. We conducted
an alternative split procedure for the VUmc Alzheimer Cen-
ter cohort (n5 1117), as a subsample (n5 206) of this cohort
was used for the validation of the original A-IADL-Q. We
therefore assigned this entire subsample to the current
training set. From the remaining subjects (n 5 911), we
randomly assigned 35% to our training set and 65% to our
validation set, to ensure that both sets had equal group sizes.
2.3.1. Development procedure
Item selection was performed in the training set, using a
stepwise procedure that combined missing data, IRT, and
content aspects. As shown in Fig. 1, a response is scored as
missing when (1) the particular task has not been performed
because of other reasons rather than cognitive problems, or
(2) the study partner does not know whether the subject has
performed that particular task in the past 4 weeks. Items
with higher percentages of missing responses give us a less
direct view of cognitive IADL, and are thus less applicable
for our goal. We therefore eliminated items with more than
80% overall missing data. Items withmore than 60%missing
data in all diagnostic groups were candidates for elimination.
2.3.1.1. IRT analyses
We explored whether all items met the basic assumptions
for IRT and eliminated items that did not meet these condi-
tions. In the subsequent refitting rounds, we used IRT to iden-
tify items that contributed little unique information to the
model, as reflected in either low item information values
(an index representing the precision with which the trait is
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mapping of the item information to the domain of the trait
indicating how the information is distributed over the trait)
with other items. After each elimination round, the GRM
was refitted and an overall fit assessment was performed.
This resulted in new item parameters and IICs that were
used in the succeeding refitting round.
2.3.1.2. Content aspects
Comprehensibilitywas investigated in twoways: (1) by in-
specting the comments that respondents provided in the
“comment box” after completing the A-IADL-Q; and (2) per-
forming thinking-out-loud interviews in a subsample of
respondents (n 5 17) while they were completing the
A-IADL-Q. Items that were often commented as unclear or
redundant, in either the comment box or interview, were can-
didates for removal. Furthermore, we investigated relevance
and cultural applicability of all A-IADL-Q items with an on-
line survey that we distributed among international experts.
Between February 2016 and May 2016, we distributed the
survey through contacts of the authors (R.J.J. and S.A.M.S.)
via Qualtrics (www.qualtrics.com). All respondents
(n 5 33) were clinicians or researchers representing seven
countries and had experience with the administration or
cross-cultural validation of the A-IADL-Q. They were asked
to rate the necessity of each original A-IADL-Q item for in-
clusion in the short version on a visual analogue scale ranging
from 0 (“not necessary at all”) to 100 (“very necessary”).
2.3.2. Validation procedure
To confirm the quality of the final short version, we inves-
tigated missing data patterns, experts’ ratings, adherence to
IRTassumptions, and the overall fit of the short version items
in the validation set. We subsequently investigated internal
consistency of the short version and concordance between
sum-scores derived from the short and original version. To
assess construct validity [33], we investigated the relation-
ship between the short version and measures of global cogni-
tion (Mini–Mental State Examination; MMSE [34]) and
daily function (Disability Assessment for Dementia; DAD
[35]), which were available for the VUmc Alzheimer
Center cohort. Based on previous results [19], we expected
moderate-to-high concordance between the short version
and MMSE and DAD scores. To assess interpretability of
the short version, we investigated differences in scores be-
tween six diagnostic groups that should represent different
trait levels: (1) NC; (2) subjective cognitive decline (SCD);
(3) MCI; (4) dementia caused by AD (AD dementia); (5) de-
mentia other than AD (non-AD dementia); and (6) another
neurologic or psychiatric disorder than dementia (Other).2.4. Statistical analyses
Statistical analyses were performed using R and SPSS
version 20.0 [36,37]. Statistical significance (for
multiplicity corrections) was set at P , .05.2.4.1. Development analyses
Item selection was partly based on IRT modeling. We
used a GRM with a logit link function [29]. This model
was fitted on the basis of approximate marginal maximum
likelihood estimation [38]. The latent trait was assumed to
follow a standard normal distribution. We assessed unidi-
mensionality by performing an eigenvalue decomposition
on the matrix of robust (Spearman) correlations between
the items. A difference approximation to the second-order
derivatives along the eigenvalue curve (scree plot) was
calculated. This acceleration-approximation indicates points
of abrupt change along the eigenvalue curve [39]. The num-
ber of eigenvalues before the point with the most abrupt
change (the point with the maximum acceleration value) rep-
resents the number of latent dimensions that dominate the in-
formation content. Local independence was assessed by
inspecting residual correlation matrices. We considered re-
sidual correlations .0.25 as indicative of problematic item
pairs. We evaluated the monotonicity assumption using
Mokken scale analysis [40]. Items that gave at least one sig-
nificant violation of manifest monotonicity and had a crit
value .30 were considered to violate latent monotonicity
[41]. We assessed basic model fit by comparing nested
models: we used a likelihood ratio test (LRT) to evaluate if
the full GRM provided a better fit than a constrained GRM
with equal slope parameters across items [28].
2.4.2. Validation analyses
We fitted a GRM on the final set of retained items. Estima-
tion and assumption evaluation for thismodelwere performed
as described previously. Thismodelwas also comparedwith a
constrainedGRMas ameans of basicmodel fit assessment. In
addition, we evaluated global fitness of the final model with
the comparative fit index (CFI) and root mean square error
of approximation (RMSEA) [42]. Trait (or factor) scores
were then based on empirical Bayes estimates: the mode of
the posterior distribution of the trait given the retained items
evaluated at the marginal maximum likelihood estimates.
We calculated internal consistency of the retained items using
a robust version of McDonald’s omega [43]. We examined
concordance between sum-scores derived from the short and
original versions, and between short version sum-scores and
MMSE and DAD scores, using Kendall’s W [44]. To assess
whether the short version scores differed between the diag-
nostic groups, we used a Kruskal-Wallis rank sum test on
the trait scores followed by Dunn’s pairwise test for multiple
comparisons of mean rank sums (a nonparametric alternative
to analysis of variance followed by post hoc tests) [45]. Mul-
tiple testing correction was based on the Bonferroni method.3. Results
3.1. Sample and item characteristics
The study sample consisted of subjects with NC
(n 5 104), SCD (n 5 219), MCI (n 5 138), AD dementia
Table 1
Subject characteristics
Total sample
(n 5 1355)
Training set
(n 5 677)
Validation set
(n 5 678) P value
Age, M (SD) 65.7 (9.7) 66.1 (10.1) 65.3 (9.2) .146*
Gender, female (%) 602 (44.4%) 301 (44.5%) 301 (44.4%) .981y
Diagnosis
NC 104 (7.7%) 52 (7.7%) 52 (7.6%)
SCD 219 (16.2%) 116 (17.1%) 103 (15.2%)
MCI 138 (10.2%) 84 (12.4%) 54 (8.0%)
AD dementia 413 (30.5%) 209 (30.9%) 204 (30.1%)
Non-AD dementia 235 (17.3%) 100 (14.8%) 135 (19.9%)
Other 246 (18.2%) 116 (17.1%) 130 (19.2%)
Abbreviations: AD, Alzheimer’s disease; MCI, mild cognitive impair-
ment; NC, normal cognition; SCD, subjective cognitive decline; SD,
standard deviation.
*Tested using independent t test.
yTested using Pearson’s chi-square test.
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with other diagnoses. Table 1 shows subject characteristics
for the total sample and for the training and validation set
separately. There were no age and gender differences be-
tween the two sets. The MCI group was slightly larger in
the training set, whereas the non-AD dementia group was
slightly larger in the validation set.
Missing responses on the item level in the training set
ranged from 10.5% (“preparing sandwich meals”) toOriginal A-IADL-Q: 70 items
61 items
50 items
42 items
9 ite
- m
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Fig. 2. Flowchart of the item selection procedure that led to the short version of
Instrumental Activities of Daily Living; IRT, Item Response Theory.92.8% (“programming a video recorder”). Approximately
half of the original version items (36/70) contained more
than 50% missing data. Mean ratings from the 33 experts
ranged from 23.9 (“programming a video recorder”) to
86.9 (“paying when doing the shopping”), with an overall
mean score of 62.3 (standard deviation 5 14.9).3.2. Development of the short version
Fig. 2 provides a flowchart of the item selection proced-
ure. Our first step included the removal of two items that
violated the assumption of monotonicity, together with seven
items that contained more than 80% missing data. After the
second round, we removed 11 items with missing responses
more than 60% in all diagnostic groups and contributing little
information to the model (item information,3.0). After the
third round, we removed eight items that received low ratings
of experts (mean rating,50) and had often been commented
on as either unclear or redundant by respondents. We there-
after removed six items with overlapping IICs and overlap-
ping content with other items within the same activity
category (e.g., “cooking” versus “preparing hot meals”). Of
these overlapping pairs, we removed the one containing
highermissing data and lower content rating. After the fourth
round, we removed four items that were often perceived as
unclear and showed overlapping IICs with more specificms removed due to
issing data > 80 %
iolation IRT assumptions
ems removed due to:
missing data in all groups > 60%
item information value < 3.0
ms removed due to:
low expert ratings
often critizied by respondents
ms removed due to:
overlapping content within activity category
overlapping item information curves
ms removed due to:
erceived as unclear by respondents
verlapping item information curves
ms removed due to:
dditional comments of experts
the Amsterdam IADL Questionnaire (A-IADL-Q). Abbreviations: IADL,
Table 2
Final selection of the short version items, including their missing data percentages, GRM parameters, item information values, and content ratings by experts
Item % Missing
Item parameters
Item information Expert ratinga b1 b2 b3 b4
1 Carrying out household duties 12.1 1.830 20.653 0.259 1.309 2.209 4.73 76
2 Doing the shopping 14.3 2.027 20.597 0.481 1.206 1.732 4.93 79
4 Buying the correct articles 34.8 1.505 20.209 0.795 1.249 1.282 2.57 73
6 Cooking 33.8 2.236 20.613 0.426 0.990 1.388 5.25 76
9 Preparing sandwich meals 10.0 2.454 0.643 1.602 2.266 2.524 5.82 60
10 Making minor repairs to the house 53.1 2.330 20.867 20.013 0.510 0.897 5.28 60
11 Operating domestic appliances 8.3 2.120 20.074 0.865 1.544 2.142 5.17 63
12 Operating the microwave oven 30.4 1.938 0.134 0.880 1.351 1.711 3.83 58
16 Operating the coffee maker 11.4 2.751 0.598 1.302 1.731 1.913 5.82 63
17 Operating the washing machine 42.0 3.662 0.584 1.254 1.533 1.610 7.71 58
19 Paying bills 34.4 2.659 20.467 0.417 0.717 0.904 5.55 83
22 Using a mobile phone 17.0 2.126 20.416 0.531 1.148 1.658 5 76
23 Managing the household budget 45.0 2.884 20.773 0.138 0.448 0.738 6.56 79
25 Using electronic banking 46.9 3.632 20.320 0.285 0.500 0.560 7.12 66
28 Using a pin code 11.8 2.030 0.190 1.082 1.533 1.984 4.34 77
29 Obtaining money from a cash machine 32.7 3.486 0.397 0.892 1.316 1.484 7.59 69
30 Paying using cash 15.6 2.665 0.415 1.288 1.712 2.257 6.59 72
31 Making appointments 17.4 1.945 20.660 0.270 1.363 1.945 4.33 75
32 Filling in forms 24.8 2.516 20.792 0.173 0.754 1.307 5.95 66
33 Working 47.1 1.579 20.965 20.237 0.379 0.742 2.95 70
35 Using a computer 22.6 2.229 20.718 0.193 0.846 1.418 5.47 68
37 Emailing 44.0 3.100 20.297 0.293 0.789 1.024 7.01 54
39 Printing documents 56.6 4.080 20.059 0.653 0.814 0.857 8.3 70
46 Operating devices 16.4 3.374 20.367 0.584 1.243 1.869 10.3 72
47 Operating the remote control 3.1 1.786 0.017 1.073 1.734 2.599 4.32 80
57 Playing card and board games 50.9 1.657 20.462 0.556 1.194 1.662 3.49 62
59 Driving a car 25.7 1.592 20.351 0.569 1.015 1.300 2.93 76
65 Using a sat-nav system 51.6 2.421 20.394 0.384 0.777 0.823 4.62 61
66 Using public transport 47.9 3.123 20.071 0.420 0.878 1.200 7.01 83
70 Being responsible for his/her own medication 27.7 1.478 20.075 1.005 1.685 2.361 3.16 82
Abbreviations: GRM, Graded Response Model; a, discrimination parameter; b’s, extremity parameters.
NOTE. Percentagemissing, parameter estimates, and information characteristics are based on the validation set. Expert ratings weremade per item on a visual
analogue scale ranging from 0 to 100.
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“looking for his/her keys”). Finally, we removed two items
because of disputable item characteristics and additional
comments of experts. After this, we refitted the model with
the remaining 30 items and concluded that further shortening
was unnecessary. All 30 retained items in the training set
were deemed to contribute substantially unique information
to the latent trait. The full GRM improved fit on the con-
strained GRM (LRT value 5 98.01, df5 29, P , .001).3.3. Validation of the short version
The final selection of items can be found in column 1
of Table 2. This selection adheres to all assumptions un-
derlying the IRT framework. The maximum acceleration
factor on the consecutive eigenvalues of the robust corre-
lation matrix occurs at the second eigenvalue (with a value
of 1.26), implying that the first eigenvalue (with a value of
17.09) dominates the information content. Hence, a single
latent dimension is sufficient. Moreover, no item pair
sorted a residual correlation .0.25 and no item displayed
significant violations of manifest monotonicity. Table 2also presents information on missing percentages and the
estimated GRM parameters based on the validation set.
The last column shows the experts’ ratings. As can be
seen, all retained items contain less than 60% missing
data and most items (26/30) had less than 50% missing
data in the validation set. The extremity parameters were
spread along the latent trait continuum (ranging from
24 to 14), which is also illustrated by the IICs presented
in Fig. 3. For most items, item information values were
more than 3 (on a total information of 163.68). Finally,
all short version items received medium-to-high ratings
from experts.
The full GRM provided better fit on the validation data
than the constrained GRM (LRT value 5 6644.47,
df 5 29, P , .001). The overall fit of the final model was
considered good: CFI 5 0.994, RMSEA 5 0.032. Internal
consistency of the short version was very high (robust
McDonald’s omega 5 0.98). Concordance between the
item sum-scores of the short version and the original version
was also very high (Kendall’sW5 0.97). Concordance with
the MMSE (Kendall’s W 5 0.72) and DAD (Kendall’s
W 5 0.87) was high.
Fig. 3. Item information curves of the 30 Amsterdam IADL items that resulted in the short version. The bold black line represents the total test information
curve. The latent trait ranges from 24 (good IADL functioning) to 14 (poor IADL functioning). Abbreviation: IADL, instrumental activities of daily living.
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diagnostic groups within the validation set. Fig. 4 represents
the trait score distributions for each diagnostic group. It can
be seen that this score seems to increase from NC to demen-
tia. The variances of the trait scores were not equal between
diagnostic groups. Hence, a nonparametric test was used to
assess diagnostic group differences between latent trait
scores as derived from the final GRM. The Kruskal-Wallis
rank sum test indicated that the mean trait score ranks of
the diagnosis groups indeed differed (c2 5 187.01, df 5 5,
P, .001). Pairwise comparisons (Dunn’s test) with the Bon-
ferroni correction indicated the following pairwise differ-
ences: (1) NC versus all other groups (all corrected P
values ,.001); (2) SCD versus AD dementia, non-AD de-
mentia, and Other group (all corrected P values ,.001);
and (3)MCI versus AD dementia (corrected P value5 .002).4. Discussion
We designed a short version of the A-IADL-Q containing
30 items. We thereby reduced administration time by
approximately 10 minutes. We showed that, although sig-
nificantly shorter, the A-IADL-Q-SV has maintained theTable 3
Clinical characteristics of different diagnostic groups in the validation set
NC (n 5 52) SCD (n 5 103) MCI (n 5 54) A
Gender, female (%) 30 (57.7%) 43 (41.7%) 18 (33.3%) 1
Age, M (SD) 70.5 (7.6) 62.8 (10.2) 69.8 (9.3) 66
MMSE score, M (SD) NA 27.3 (2.2) 26.6 (2.1) 20
DAD score, M (SD) NA 91.0 (12.6) 86.5 (14.3) 78
Abbreviations: AD, Alzheimer’s disease; DAD, Disability Assessment for Deme
mild cognitive impairment; MMSE, Mini–Mental State Examination (higher score
normal cognition; SCD, subjective cognitive decline; SD, standard deviation.psychometric quality of the original A-IADL-Q. We demon-
strated adequate measurement precision along the entire
spectrum of IADL functioning. Short version scores were
in high concordance with the MMSE and DAD, which sup-
ports the construct validity of the A-IADL-Q-SV. We also
found that the A-IADL-Q-SV could differentiate between
various diagnostic groups with respect to IADL impairment.
The present study expands on previous work on the
A-IADL-Q, which already demonstrated good psychometric
quality of the scale [18–21]. The A-IADL-Q-SV contains
only the most informative items, and thereby possible
“noise” caused by less informative or ambiguous items has
been reduced. Because of its reduced length, the A-IADL-
Q-SV may be perceived as a more user-friendly measure.
The use of shorter tests is also encouraged from a psycho-
metric point of view: a short form containing items of the
same quality as the original form may yield less measure-
ment error and thus be more reliable [28]. Longer tests are
more likely to suffer from acquiescence bias and missing re-
sponses. Using the A-IADL-Q-SV may overcome these test-
length related drawbacks.
Our findings suggest that the A-IADL-Q-SV can already
detect IADL problems in subjects with SCD andMCI, whichD dementia (n 5 204) Non-AD dementia (n 5 135) Other (n 5 130)
11 (54.4%) 57 (42.2%) 42 (32.3%)
.9 (8.9) 66.5 (8.5) 60.8 (9.9)
.1 (4.8) 23.7 (4.4) 25.3 (4.3)
.2 (20.6) 75.7 (25) 76.6 (23.7)
ntia (lower scores reflect more dysfunction in activities of daily living); MCI,
s reflect better cognitive functioning); NA, not available for this cohort; NC,
Fig. 4. Short version latent trait scores for each diagnostic group. Latent trait scores reflect IADL functioning, with higher scores indicating poorer IADL func-
tioning. Post hoc analyses gave the following significant pairwise differences: (1) NC versus all other groups; (2) SCD versus AD dementia, non-AD dementia,
and Other group; and (3) MCI versus AD dementia. Abbreviations: AD, Alzheimer’s disease; IADL, instrumental activities of daily living; MCI, mild cognitive
impairment; NC, normal cognition; SCD, subjective cognitive decline.
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impairment in these groups [46–48]. We found that IADL
scores differed between subjects with NC and SCD. This is
of particular interest because both groups are characterized
by the absence of objective cognitive impairment, although
SCD subjects may be at higher risk of developing dementia
[49]. The A-IADL-Q-SV might thus be able to detect subtle
functional decline that appears in preclinical stages of de-
mentia, suggesting that it could be a promising measure for
clinical trials in these earliest stages [10,50].
Strengths of this study include our large and heterogenic
sample with subjects covering a broad range of the IADL
spectrum along the continuum from normal aging to
dementia. Another strength is the use of a validation set to
replicate findings derived from the training set. After split-
ting the total sample, the training and validation set both
contained more than 500 subjects, a number that is recom-
mended for estimating accurate parameters based on the
GRM [51]. Finally, combining statistical methods with input
from respondents and experts is an important strength of this
study, as it preserved both the psychometric quality and clin-
ical relevance of the A-IADL-Q-SV.
There are some limitations that should be considered.
Among them are our relatively small NC group, because of
the fact that most subjects were recruited via memory clinics.
Secondly, previous studies have shown that proxy-based
IADLmeasures may be confounded by respondent character-
istics such as caregiver burden and depression [52]. We did
not take these characteristics into account in the present study.
However, Sikkes et al. showed low correlations between theoriginal A-IADL-Q, caregiver burden, and depression, indi-
cating limited confounding by these variables [19].
Further research is needed to examine whether the
A-IADL-Q-SV is sensitive to changes over time within sub-
jects. We will investigate the A-IADL-Q-SV longitudinally
in subjects with MCI and early dementia to determine
whether it could be an effective measure for monitoring dis-
ease progression and evaluating disease-modifying therapies.
Because the research field is shifting toward preclinical stages
of dementia, it is also relevant to further investigate the
A-IADL-Q-SV in subjects with SCD and the relation between
IADL scores and dementia biomarkers in this group.
To conclude, we developed the A-IADL-Q-SV, which is a
concise instrument to efficiently measure functional decline
in the early stages of dementia.TheA-IADL-Q-SVhas retained
the good qualities of the original A-IADL-Q; hence, we expect
the A-IADL-Q-SV to be a promising outcome measure for
daily function in dementia research and clinical practice.Acknowledgments
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1. Systematic review: The Amsterdam IADL Question-
naire (A-IADL-Q) was developed to detect problems
in instrumental activities of daily living (IADL) in
subjects with incipient dementia. Previous validation
studies have demonstrated good psychometric prop-
erties. However, a shorter version is desired to facil-
itate administration and implementation on a wider
scale. We therefore aimed to design and validate a
short version of the A-IADL-Q (A-IADL-Q-SV).
2. Interpretation: We developed an A-IADL-Q-SV that
consists of 30 items, resulting in an administration
time of 10 to 15 minutes. The A-IADL-Q-SV has
maintained the psychometric quality of the original
version. We demonstrated adequate measurement
precision along the entire spectrum of IADL func-
tioning from normal aging to dementia.
3. Future directions: The A-IADL-Q-SV will be inves-
tigated longitudinally in subjects with early stages of
dementia, to determine whether it could be an effec-
tive measure for the monitoring of disease progres-
sion and evaluation of symptomatic treatments.
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